Specialties & Topics
- Arthritis/Rheumatic Disease
- Breast Cancer
- GERD/Peptic Ulcers
An ongoing dialogue on HIV/AIDS, infectious diseases,
July 1st, 2012
“HAART Era” Now Longer Than “Pre-HAART Era” — Can We Officially Retire “HAART”?
(I’m a fun guy to have at parties.)
I’m returning to this pet peeve of mine because I realized recently that we’ve passed a milestone of sorts:
- Period of no effective HIV treatment, 15 years (1981-1996)
- Period of effective HIV treatment, 16 years (1996-2012)
I came to this realization while reviewing a manuscript on an HIV-related complication. The author repeatedly (and at great length) described how this complication had changed with the “advent of HAART” (cringe) –incidence down, prognosis better, management altered. There were many comparisons between the “pre-HAART era” and the “post-HAART era”, even a separate table on the differences.
Of historical interest, yes, but hardly earth-shattering news at this point , and not of much practical use to the reader –pretty much everything changed with effective HIV treatment.
The bottom line is that HIV-related complications should be considered now only in the context of patients who are receiving, or who are about to receive, antiretroviral therapy. In other words, describing how to manage HIV-related complications without HIV treatment would be like an endocrinologist describing management of Type 1 diabetes complications without insulin.
So since HIV treatment is now the new normal — becoming more so with each passing year — let’s just call it antiretroviral therapy, and assume that it’s standard of care to give the highly active kind.
And if you want to abbreviate it, “ART” will do just fine.
Leave a Reply
Paul E. Sax, MD
Learn more about HIV and ID Observations.
- It’s Time to Dump the HIV Western Blot
- Anti-Vaccine Movement Slammed By Daily Show; ID Doctors, Pediatricians Happy
- CROI 2015 Dates Announced — And Warning, It’s Still Winter in Boston
- Some ID Stuff We’re Talking About on Rounds
- Simeprevir and (Especially) Sofosbuvir Are Great Leaps Forward — and They Will Cost Plenty
- Ebola Virus Disease in Guinea (FREE)
- Zoster Vaccine Effective When Given Before Immunosuppression in Older Adults
- Fluoroquinolone Antibiotics and Risk for Polyneuropathy
- Tetracycline and Furazolidone Quadruple Rescue Therapy for Helicobacter pylori
- Are Empirical β-Lactams Underdosed in Critically Ill Patients?
Physician's First WatchToday's breaking medical news